West Pharmaceutical Services | WST - Current Liabilities

Stock Price
237.43
Daily Change
6.31 2.73%
Monthly
-14.91%
Yearly
-29.55%
Q1 Forecast
224.00

West Pharmaceutical Services reported $635.4M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Align Technology USD 1.97B 29.02M Sep/2025
Avanos Medical USD 147.9M 13.3M Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Becton, Dickinson and Co. USD 8.31B 153M Sep/2025
Charles River Laboratories USD 1.12B 41.45M Sep/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Dentsply International USD 1.4B 239M Sep/2025
Haemonetics USD 548.32M 16.91M Sep/2025
ICU Medical USD 492.9M 10.12M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
IQVIA Holdings USD 8.51B 936M Sep/2025
J&J USD 50.87B 3.31B Sep/2025
Medtronic USD 11.53B 1.35B Jun/2025
Merit Medical Systems USD 230.48M 4.9M Sep/2025
Neogen USD 147.05M 850K Sep/2025
Quidel USD 767.9M 374.2M Sep/2025
Repligen USD 131.14M 8.12M Sep/2025
Solventum Corp USD 2.94B 318M Sep/2025
STAAR Surgical USD 61.64M 2.41M Sep/2025
Terumo JPY 296.3B 24.4B Sep/2025
West Pharmaceutical Services USD 635.4M 30.8M Sep/2025